Literature DB >> 25282339

Inflammasome activation in response to dead cells and their metabolites.

Hajime Kono1, Yoshitaka Kimura2, Eicke Latz3.   

Abstract

Cell death cannot go unnoticed. It demands that the surrounding cells clear away the corpses in a manner appropriate to the type of cell death. Dying cells represent a threat to the body that should be eliminated by the host immune response. Inflammasome activation followed by IL-1alpha release and IL-1beta maturation is crucial for tackling pathological conditions, including infections, whereas inflammasome activation precedes inflammatory pyroptotic cell death. On the other hand, recent studies have shown that the inflammasome plays an important role in the pathogenesis of metabolic diseases, including obesity, diabetes, and atherosclerosis. Here, we review current knowledge of the association between cell death, excess metabolites, and inflammasome activation as it relates to chronic inflammatory diseases.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25282339     DOI: 10.1016/j.coi.2014.09.001

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  23 in total

Review 1.  Is immunity a mechanism contributing to statin-induced diabetes?

Authors:  Brandyn D Henriksbo; Jonathan D Schertzer
Journal:  Adipocyte       Date:  2015-04-20       Impact factor: 4.534

Review 2.  The Possibility and Molecular Mechanisms of Cell Pyroptosis After Cerebral Ischemia.

Authors:  Zhaofei Dong; Kuang Pan; Jingrui Pan; Qingxia Peng; Yidong Wang
Journal:  Neurosci Bull       Date:  2018-10-10       Impact factor: 5.203

3.  Sex- and disease-specific inflammasome signatures in circulating blood leukocytes of patients with abdominal aortic aneurysm.

Authors:  Xiaoyu Wu; Sinan Cakmak; Markus Wortmann; Maani Hakimi; Jian Zhang; Dittmar Böckler; Susanne Dihlmann
Journal:  Mol Med       Date:  2016-07-29       Impact factor: 6.354

Review 4.  Role of innate and adaptive immune mechanisms in cardiac injury and repair.

Authors:  Slava Epelman; Peter P Liu; Douglas L Mann
Journal:  Nat Rev Immunol       Date:  2015-02       Impact factor: 53.106

Review 5.  Cell Death Mechanisms in Cerebral Ischemia-Reperfusion Injury.

Authors:  Qian Zhang; Meng Jia; YunFu Wang; Qun Wang; Jianping Wu
Journal:  Neurochem Res       Date:  2022-08-17       Impact factor: 4.414

Review 6.  Relevant mediators involved in and therapies targeting the inflammatory response induced by activation of the NLRP3 inflammasome in ischemic stroke.

Authors:  Qingxue Xu; Bo Zhao; Yingze Ye; Yina Li; Yonggang Zhang; Xiaoxing Xiong; Lijuan Gu
Journal:  J Neuroinflammation       Date:  2021-05-31       Impact factor: 8.322

7.  Formulative Study and Intracellular Fate Evaluation of Ethosomes and Transethosomes for Vitamin D3 Delivery.

Authors:  Manuela Costanzo; Elisabetta Esposito; Maddalena Sguizzato; Maria Assunta Lacavalla; Markus Drechsler; Giuseppe Valacchi; Carlo Zancanaro; Manuela Malatesta
Journal:  Int J Mol Sci       Date:  2021-05-19       Impact factor: 5.923

8.  Gene expression of inflammasome components in peripheral blood mononuclear cells (PBMC) of vascular patients increases with age.

Authors:  Xiaoyu Wu; Maani Hakimi; Markus Wortmann; Jian Zhang; Dittmar Böckler; Susanne Dihlmann
Journal:  Immun Ageing       Date:  2015-10-06       Impact factor: 6.400

Review 9.  Chemical Modulation of Gasdermin-Mediated Pyroptosis and Therapeutic Potential.

Authors:  Christopher B Ryder; Hannah C Kondolf; Meghan E O'Keefe; Bowen Zhou; Derek W Abbott
Journal:  J Mol Biol       Date:  2021-08-03       Impact factor: 5.469

10.  Microglial signalling pathway deficits associated with the patient derived R47H TREM2 variants linked to AD indicate inability to activate inflammasome.

Authors:  Katharina Cosker; Anna Mallach; Janhavi Limaye; Thomas M Piers; James Staddon; Stephen J Neame; John Hardy; Jennifer M Pocock
Journal:  Sci Rep       Date:  2021-06-25       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.